Weber, J. Del Vecchio, M. Mandala, M. Gogas, H. Arance Fernandez, A. M. Dalle, S. Cowey, C. L. Schenker, M. and Grob, J-J. Sileni, V. Chiarion Marquez-Rodas, I. Butler, M. O. Maio, M. Middleton, M. de la Cruz Merino, L. Lobo, M. and de Pril, V. Larkin, J. Ascierto, P. A., Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV
melanoma: 4-y recurrence-free and overall survival (OS) results from
CheckMate 238, Annals of Oncology, (31), S731-S732, 2020, Elsevier, 0923-7534, 1569-8041